Patent Assignment
Reel/Frame 071298/0097
Change of Name
Recorded: 2025-05-20
Pages: 6
Assignor
ALBANY MOLECULAR RESEARCH, INC.
Executed: 2021-07-06
Assignee
CURIA GLOBAL, INC.
24 CORPORATE CIRCLE, ALBANY, NEW YORK, 12203
Covered Properties
(28)
Novel Cyclosporins
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Novel Cyclosporin Analogues and Their Pharmaceutical Uses
Novel Processes for Stereoselective Synthesis of Trans ISATX247
Novel Cyclosporin Alkynes and Their Utility as Pharmaceutical Agents
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Process for Production of Piperidine Derivatives
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
5-HT3 Receptor Modulators, Methods of Making, and Use Thereof
2-Aminobenzoxazole Process
Process for Production of Carebastine
Process for Production of Piperidine Derivatives
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Tetrahydroisoquinolines and Intermediates Therefor
Process for Production of Delta-9-Tetrahydrocannabinol
Glycine Transporter-1 Inhibitors, Methods of Making Them, and Uses Thereof
5-HT3 Receptor Modulators, Methods of Making, and Use Thereof
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
5-HT3 Receptor Modulators, Methods of Making, and Use Thereof
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Ultrapure Tetrahydrocannabinol-11-Oic Acids
Methods and Compositions for Preventing Opioid Abuse
Methods and Compositions for Preventing Opioid Abuse
Methods and Intermediates for the Preparation of Omacetaxine and Cephalotaxine Derivatives Thereof
Ultrapure Tetrahydrocannabinol-11-Oic Acids
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
Security Interest
Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
Security Interest
Aug 5, 2015
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI SSCI, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 036257/0914 →
Assignment of Assignor's Interest
Jun 22, 2016
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 039116/0827 →
Release of Security Interest
Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
Reel/Frame 043742/0085 →
Second Lien Security Agreement
Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
First Lien Security Agreement
Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
Corrective Assignment to Correct the Incorrect Patent No. 7541537 Previously Recorded at Reel: 034045 Frame: 0951. Assignor(S) Hereby Confirms the Security Interest.
Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
Release of Security Interest
Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
Reel/Frame 054252/0687 →
Release of Security Interest
Nov 16, 2020
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 054382/0326 →
Security Interest
Sep 6, 2021
From: CURIA GLOBAL, INC. (FKA ALBANY MOLECULAR RESEARCH, INC.); CURIA MASSACHUSETTS, INC. (FKA AMRI BURLINGTON, INC.); CURIA WISCONSIN, INC. (FKA CEDARBURG PHARMACEUTICALS, INC.); CURIA INDIANA, LLC (FKA AMRI SSCI, LLC)
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 057423/0665 →
Security Interest
Mar 7, 2025
From: CURIA GLOBAL, INC.; CURIA IP HOLDINGS, LLC; CURIA BIO, INC.
To: APOLLO ADMINISTRATIVE AGENCY LLC
Reel/Frame 070442/0908 →
Assignment of Security Interest in Intellectual Property, Recorded on September 1, 2017, at Reel/Frame 043746/0621
Mar 17, 2025
From: BARCLAYS BANK PLC, AS EXISTING AGENT
To: APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT
Reel/Frame 070531/0279 →
Partial Release of First Lien Intellectual Property Security Agreement Supplement
Jun 3, 2025
From: APOLLO ADMINISTRATIVE AGENCY LLC
To: CURIA GLOBAL, INC.
Reel/Frame 071490/0880 →
Assignment of Assignor's Interest
Dec 3, 2025
From: CURIA GLOBAL, INC.
To: CURIA BUFFALO R&D, LLC
Reel/Frame 073096/0462 →